PDCD1 and melanoma: A major pathway through which tumors induce immunosuppression involves binding of programmed death ligand 1 (PD-L1), expressed on the surface of melanoma cells, on to its receptor programmed cell death 1 (PD-1), a coinhibitory surface checkpoint receptor on T cells (17, 18).